Broncus Medical Revenue and Competitors
Estimated Revenue & Valuation
- Broncus Medical's estimated annual revenue is currently $23.3M per year.
- Broncus Medical's estimated revenue per employee is $251,000
- Broncus Medical's total funding is $154.1M.
Employee Data
- Broncus Medical has 93 Employees.
- Broncus Medical grew their employee count by -6% last year.
Broncus Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Head Finance | Reveal Email/Phone |
2 | Sr Director Sales & Marketing Europe | Reveal Email/Phone |
3 | Sr. Director Clinical Affairs | Reveal Email/Phone |
4 | Director, Software R&D, Global | Reveal Email/Phone |
5 | Sr. Manager Clinical Education EU and UK | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
7 | Sr. Quality Specialist/Document Control Manager | Reveal Email/Phone |
8 | Manager Clinical Education | Reveal Email/Phone |
9 | Senior QA Manager | Reveal Email/Phone |
10 | Regional Territory Manager-South Central | Reveal Email/Phone |
Broncus Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7M | 56 | -23% | $152.9M | N/A |
What Is Broncus Medical?
Broncus is developing devices designed to deliver less-invasive solutions to patients with asthma and emphysema. These devices are introduced into the lungs through the mouth and throat, using a bronchoscope. (A bronchoscope is a flexible tubular camera used for inspecting or passing instruments into the lungs.)
keywords:N/A$154.1M
Total Funding
93
Number of Employees
$23.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Broncus Medical News
HANGZHOU, China, March 30, 2022 /PRNewswire/ -- On March 29, 2022, Broncus Medical (02216.HK), the leader in precision interventional...
For example, when compared to LungPoint (Broncus Medical, Mountain View, CA), a globally used bronchoscopic navigation system, VINCENT-BFsim...
Broncus Medical, Inc. is dedicated to the development of diagnostic and therapeutic technology for a variety of lung diseases. Founded in 2012,...
Qiming Venture Partners has led a 320 million yuan ($49.5 million) Series B round of financing for Sunyur, while Broncus Holding Corporation, a Chinese medical device firm also backed by Qiming, has raised HK$1.671 billion ($214.7 million) in an initial public offering (IPO) in Hong Kong. Qiming ...
Broncus Holding Company, a Hangzhou, China-based global leader in diagnostic and therapeutic technology for lung diseases, closed a Series C round of funding. The round was led by Lake Bleu Capital, with participation from Baidu Capital, Ascendum Capital, CNCB Capital and DCP Capital, along wit ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.6M | 93 | 2% | $47M |
#2 | $22.8M | 93 | -11% | $4.8M |
#3 | $13.2M | 94 | 6% | N/A |
#4 | $14.1M | 94 | 18% | N/A |
#5 | $16.3M | 95 | 7% | N/A |